Evidence map›Paper›PMID 38397981›Full record

ReviewBiomedicines2024

Diagnostic and Therapeutic Management of Primary Orbital Neuroendocrine Tumors (NETs): Systematic Literature Review and Clinical Case Presentation.

Giulia Arrivi, Monia Specchia, Emanuela Pilozzi, Maria Rinzivillo, Damiano Caruso, Curzio Santangeli, Daniela Prosperi, Anna Maria Ascolese, Francesco Panzuto, Federica Mazzuca

Open access · goldAbstract readReview
In one paragraph

Review in Biomedicines, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Giulia ArriviOncology Unit, Department of Clinical and Molecular Medicine, Sant'Andrea University Hospital, Sapienza University of Rome, Grottarossa Street 1035-1039, 00189 Rome, Italy.ORCID 0000-0003-0541-415X
Monia SpecchiaOncology Unit, Department of Clinical and Molecular Medicine, Sant'Andrea University Hospital, Sapienza University of Rome, Grottarossa Street 1035-1039, 00189 Rome, Italy.
Emanuela PilozziAnatomia Patologica Unit, Department of Clinical and Molecular Medicine, Sant'Andrea University Hospital, Sapienza University of Rome, 00189 Rome, Italy.ORCID 0000-0002-7110-9172
Maria RinzivilloEuropean Neuroendocrine Tumor Society (ENETS) Center of Excellence, Digestive Disease Unit, Sant'Andrea University Hospital, 00189 Rome, Italy.
Damiano CarusoRadiology Unit, Department of Medical Surgical Sciences and Translational Medicine, Sant'Andrea University Hospital, Sapienza University of Rome, 00189 Rome, Italy.ORCID 0000-0001-9285-4764
Curzio SantangeliRadiology Unit, Department of Medical Surgical Sciences and Translational Medicine, Sant'Andrea University Hospital, Sapienza University of Rome, 00189 Rome, Italy.
Daniela ProsperiNuclear Medicine Unit, Sant'Andrea University Hospital, 00189 Rome, Italy.
Anna Maria AscoleseRadiotherapy Oncology Unit, Department of Surgical Medical Sciences and Translational Medicine, Sant'Andrea University Hospital, Sapienza University of Rome, 00189 Rome, Italy.
Francesco PanzutoEuropean Neuroendocrine Tumor Society (ENETS) Center of Excellence, Digestive Disease Unit, Sant'Andrea University Hospital, 00189 Rome, Italy.ORCID 0000-0003-2789-4289
Federica MazzucaOncology Unit, Department of Clinical and Molecular Medicine, Sant'Andrea University Hospital, Sapienza University of Rome, Grottarossa Street 1035-1039, 00189 Rome, Italy.
Sapienza University of Rome · ITAzienda Ospedaliera Sant'Andrea · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe ocular involvement of neuroendocrine neoplasms (NENs) is uncommon and mainly represented by metastases from gastrointestinal and lung neuroendocrine tumors. Primary orbital NENs are even less common and their diagnostic and therapeutic management is a challenge.

methodsA systematic review of the literature was conducted from 1966 to September 2023 on PubMed to identify articles on orbital NENs and to summarize their clinical-pathological features, diagnosis and therapeutic management. Furthermore, we presented a case of a locally advanced retro-orbital primary neuroendocrine tumor that was referred to the certified Center of Excellence of Sant'Andrea Hospital, La Sapienza University of Rome, Italy.

resultsThe final analysis included 63 records on orbital NENs and 11 records focused on primary orbital NENs. The localization was mostly unilateral and in the right orbit; proptosis or exophthalmos represented the initial symptoms. The diagnostic work-up and therapeutic management was discussed and a diagnostic algorithm for the suspicion of primary orbital NENs was proposed.

conclusionsA multidisciplinary approach is required for the management of primary orbital NENs, emphasizing the importance of early referral to dedicated centers for prompt differential diagnosis, tailored treatment, and an improved quality of life and survival.

Indexed as

diagnosismultidisciplinary teamNETsneuroendocrine tumororbitprimary orbitaltreatment

Identifiers

PMID38397981
PMCPMC10886459
OpenAlexW4391578517

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.